Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
4,477,932
-
Shares change
-
-237,036
-
Total reported value, excl. options
-
$14,507,144
-
Value change
-
-$783,251
-
Number of buys
-
16
-
Number of sells
-
-27
-
Price
-
$3.24
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2025
62 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2025.
XBiotech Inc. - Common Shares, no par value (XBIT) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,477,932 shares
of 33,289,095 outstanding shares and own 13.45% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1,285,763 shares), VANGUARD GROUP INC (1,062,772 shares), GEODE CAPITAL MANAGEMENT, LLC (461,230 shares), STATE STREET CORP (229,695 shares), NORTHERN TRUST CORP (209,251 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (123,032 shares), MORGAN STANLEY (105,497 shares), AMERICAN CENTURY COMPANIES INC (101,658 shares), Bank of New York Mellon Corp (91,060 shares), and MILLENNIUM MANAGEMENT LLC (82,356 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.